Palestra Capital Management’s SS&C Technologies SSNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-2,310,500
Closed -$104M 29
2018
Q4
$104M Buy
2,310,500
+225,500
+11% +$10.9M 5% 12
2018
Q3
$118M Buy
2,085,000
+215,000
+11% +$11.9M 5.49% 8
2018
Q2
$97.1M Sell
1,870,000
-75,000
-4% -$3.8M 4.24% 10
2018
Q1
$104M Buy
+1,945,000
New +$96.4M 5.78% 6
2017
Q3
Sell
-996,815
Closed -$38.3M 26
2017
Q2
$38.3M Sell
996,815
-610,000
-38% -$22.7M 2.94% 20
2017
Q1
$56.9M Hold
1,606,815
4.31% 14
2016
Q4
$46M Sell
1,606,815
-609,585
-28% -$18.9M 2.58% 16
2016
Q3
$71.3M Buy
2,216,400
+817,000
+58% +$25.9M 6.78% 4
2016
Q2
$39.3M Sell
1,399,400
-376,000
-21% -$11.3M 3.16% 17
2016
Q1
$56.3M Buy
1,775,400
+57,000
+3% +$1.73M 5.33% 6
2015
Q4
$58.7M Buy
1,718,400
+43,600
+3% +$1.55M 6.79% 6
2015
Q3
$58.7M Sell
1,674,800
-434,000
-21% -$14.7M 5.65% 3
2015
Q2
$65.9M Buy
2,108,800
+594,000
+39% +$18.2M 6.44% 1
2015
Q1
$47.2M Buy
+1,514,800
New +$45M 4.15% 9

Other funds holding SSNC

Palestra Capital Management's SSNC Position: Q1 2019 in Review

Palestra Capital Management sold out of SS&C Technologies (SSNC) in Q1 2019, closing a stake of 2,310,500 shares — an estimated $104M sold.

Palestra Capital Management first reported a position in SSNC in Q1 2015 and held it in 14 quarters. The position peaked at $118M in Q3 2018. 432 funds tracked by Wall St. Rank hold SSNC as of Q1 2019.

  • Palestra Capital Management reported no remaining SS&C Technologies position as of Q1 2019 after selling out during the quarter.
  • Palestra Capital Management sold 2,310,500 SS&C Technologies shares in Q1 2019, an estimated $104M.
  • Palestra Capital Management first reported a position in SS&C Technologies in Q1 2015 and held it in 14 quarters.
  • Palestra Capital Management's SS&C Technologies position peaked at $118M in Q3 2018.
  • 432 funds tracked by Wall St. Rank held SS&C Technologies as of Q1 2019.

Based on Palestra Capital Management's 13F filing for Q1 2019, filed 15 May 2019.